Lumida
/LMRI
⌘K
LMRI

LMRI

LMRI
$11.49USD+2.68%+0.30 today

MARKET CAP

1.1B

P/E (TTM)

FWD P/E

DAY RANGE

$11 – $12

52W RANGE

$6
$19

AI Summary

Stalk
TrimMedium

LMRI has broken a key multi‐week support cluster in a Stage 3 distribution, confirming medium-term bearish control despite an intact long-term uptrend. Price is flailing around the converged EMAs after the support failure, so immediate selling risks catching a short-covering bounce. We will trim into strength on a retest of the broken support and moving averages as preferred execution zones.

  • Q2 2026 adjusted EPS of $0.20 vs $0.16 expected; net income $2.7 M turnaround.
  • Record free cash flow in Q2 2026 supports growth initiatives or buybacks.
  • Profitability under pressure as operational costs constrain margins.
Full analysis →

Buying

6

institutions

Selling

5

institutions

New Positions

3

this quarter

Filing Period

Q1 2026

latest 13-F

13-F Holdings

InstitutionActionShares HeldValueChangeChg %Weight
JH

Janus Henderson Group Plc

Q1 2026

BUY4.20 M36.13 M+2.21 M-2.0%0.01%
BI

Blackrock, Inc.

Q2 2026

SELL1.40 M15.77 M+-127.57 K+20.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

BUY1.15 M13.25 M+49.96 K+50.5%0.00%
MM

Millennium Management LLC

Q2 2026

SELL627.99 K7.08 M+-86.69 K+15.3%0.00%
PA

Point72 Asset Management, L.P.

Q2 2026

BUY280.96 K3.17 M+179.69 K+263.9%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUYNEW78.22 K882.29 K+78.22 K+0.0%0.00%
CA

Citadel Advisors LLC

Q2 2026

SELL54.38 K613.39 K+-602.21 K-89.1%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

BUYNEW19.53 K220.30 K+19.53 K+0.0%0.00%
BA

Balyasny Asset Management L.P.

Q2 2026

BUYNEW4.15 K46.84 K+4.15 K+0.0%0.00%
WP

Woodline Partners LP

Q2 2026

SELL0.000.00+-1.06 M-100.0%0.00%
RT

Renaissance Technologies LLC

Q2 2026

SELL0.000.00+-90.42 K-100.0%0.00%